Inventor · disambiguated record
Kevin W. Hunt
Also filed as: HUNT KEVIN · HUNT KEVIN W
24 granted patents·16 pending applications·96 citations·filing 2003–2025
94Inventor score
Top patents by PatentIndex Score
40 records- 0196US10208024B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·32 cites·27 claims
- 0295US11091464B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·11 cites·30 claims
- 0394US11236065B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·7 cites·30 claims
- 0493US12012395B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·3 cites·39 claims
- 0593US11390606B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·5 cites·25 claims
- 0691US12240833B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2022·Granted Mar 4, 2025·2 cites·28 claims
- 0790US12240831B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·1 cites·51 claims
- 0889US7226906B2Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted Jun 5, 2007·7 cites·26 claims
- 0985US9763942B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·5 cites·18 claims
- 1082US10154995B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 18, 2018·3 cites·18 claims
- 1181US9670208B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 6, 2017·4 cites·19 claims
- 1281US2025223278A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1378US8716498B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2013·Granted May 6, 2014·2 cites·1 claims
- 1476US9096567B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Aug 4, 2015·2 cites·31 claims
- 1576US8569522B26-substituted phenoxychroman carboxylic acid derivativesBURGESS LAURENCE E·Filed 2009·Granted Oct 29, 2013·3 cites·37 claims
- 1676US2025340526A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1774US8785445B27-phenoxychroman carboxylic acid derivativesCOOK ADAM·Filed 2009·Granted Jul 22, 2014·4 cites·14 claims
- 1874US8026233B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 1972US12448369B2Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Oct 21, 2025·0 cites·56 claims
- 2072US9556139B26-substituted phenoxychroman carboxylic acid derivativesARRAY BIOPHARMA INC·Filed 2015·Granted Jan 31, 2017·1 cites·14 claims
- 2170US12509431B21,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·30 claims
- 2268US12415794B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·29 claims
- 2365US10766881B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Sep 8, 2020·0 cites·21 claims
- 2461US2009060968A1Inhibitors of phosphatasesSAUNDERS JEFFREY O·Filed 2008·Application pending·0 cites
- 2560US7439249B2Inhibitors of phosphatasesVERTEX PHARMA·Filed 2003·Granted Oct 21, 2008·2 cites·10 claims
- 2660US2025361213A11,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2760US2023150977A1Pyridazinone compounds for the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2860US2023159513A1Pyridazinone compounds for the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2959US2025388564A1Methods of manufacturing pyridazinone compoundsEDGEWISE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3057US2024417725A1Oligonucleotides for targeting complement c5VANQUA BIO INC·Filed 2022·Application pending·0 cites
- 3156US2025230172A1Small molecule modulators of glucocerebrosidase activity and uses thereofVANQUA BIO INC·Filed 2022·Application pending·0 cites
- 3256US2025034170A1Small molecule modulators of glucocerebrosidase activity and uses thereofVANQUA BIO INC·Filed 2022·Application pending·0 cites
- 3355US2024246952A1Small molecule modulators of glucocerebrosidase activity and uses thereofVANQUA BIO INC·Filed 2022·Application pending·0 cites
- 3454US2006035821A1Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseasesHUNT KEVIN W·Filed 2004·Application pending·0 cites
- 3554US2024262832A1Small molecule modulators of glucocerebrosidase activity and uses thereofVANQUA BIO INC·Filed 2022·Application pending·0 cites
- 3653US11339150B2Benzimidazole compounds as HDAC6 inhibitorsONKURE INC·Filed 2020·Granted May 24, 2022·0 cites·23 claims
- 3743US7553842B2Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseasesARRAY BIOPHARMA INC·Filed 2006·Granted Jun 30, 2009·0 cites·26 claims
- 3839US2012065195A1Compounds for treating neurodegenerative diseasesCLARK CHRISTOPHER T·Filed 2011·Application pending·0 cites
- 3938US2012083501A1Compounds for treating neurodegenerative diseasesHUNT KEVIN W·Filed 2011·Application pending·0 cites
- 4035US2012157448A1Compounds for treating neurodegenerative diseasesCOOK ADAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin W. Hunt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →